WASHINGTON, DC - Republican members of the House Energy and Commerce Committee are seeking answers about the president’s recently issued Executive Order establishing an Interagency Working Group that will be involved in the regulation of hydraulic fracturing. Members wrote today to EPA Administrator Lisa Jackson and Chairwoman of the Working Group Heather Zichal requesting clarification of the Executive Order’s intent and the role of the federal government in natural gas regulation.
Energy and Commerce Members Press White House and EPA on Expansion of Federal Government’s Role in Natural Gas RegulationJune 19, 2012 | Press Release
WASHINGTON, DC - This week the House will vote on a package of energy bills designed to increase American energy production and create jobs. The Domestic Energy and Jobs Act is the latest energy and jobs proposal to hit the House floor this Congress as part of House Republicans’ American Energy Initiative.
WASHINGTON, DC - The House Energy and Commerce Subcommittee on Energy and Power, chaired by Rep. Ed Whitfield (R-KY), today continued its hearing on the American Energy initiative with a focus on EPA’s greenhouse gas regulations.
In preparation for a vote in the House of Representative this week, the committee released the Food and Drug Administration Safety and Innovation Act, S. 3187. Click here to view text of the legislation.
E&C Studio Releases New Video Comparing Obama’s “Heady Idealism” to Secret Deals and Advertising Agreements Behind Health Care LawJune 18, 2012 | Press Release
Click here to watch Let’s make a deal, Obama-styleAs published in The MercuryBy Rep. Joe Pitts
Upton, Waxman, Harkin, and Enzi Announce Bipartisan Agreement on Food and Drug Administration Safety and Innovation ActJune 18, 2012 | Press Release
WASHINGTON, DC - House Energy and Commerce Committee Chairman Fred Upton (R-MI), Ranking Member Henry A. Waxman (D-CA), Senate HELP Committee Chairman Tom Harkin (D-IA), and Ranking Member Mike Enzi (R-WY) today announced a bipartisan agreement on the Food and Drug Administration Safety and Innovation Act, S 3187, which reauthorizes Food and Drug Administration user fees to ensure the continuation of various FDA programs and the creation of new ones to facilitate the review and approval of life-saving and life-improving drugs and medical devices.